The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour

Pediatric Blood and Cancer

Volumn 59, Issue 4, 2012, Pages 636-641

  Israels, Trijn ^a   Chagaluka, George ^b   Pidini, Dalida ^b   Caron, Huib ^a   de Kraker, Jan ^a   Kamiza, Steve ^b   Borgstein, Eric ^b   Molyneux, Liz ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Low income country; Nephroblastoma; Preoperative chemotherapy; Sub Saharan Africa; Toxicity; Wilms

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; MALAWI; MALE; METASTASIS; NEPHROBLASTOMA; NEUTROPENIA; PREOPERATIVE CARE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACTINOMYCIN; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALAWI; MALE; NEPHRECTOMY; VINCRISTINE; WILMS TUMOR;

EID: 84864942623     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24088     Document Type: Article

References (15)

1. Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 2000;27:443-454.
2. Green DM. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol 2004; 22: 1366-1372.
3. Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001;19: 488-500.
4. Israels T, Borgstein E, Jamali M, et al. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter. Pediatr Blood Cancer 2009;53:1221-1226.
5. Tazi I, Hidane Z, Zafad S, et al. Nutritional status at diagnosis of children with malignancies in Casablanca. Pediatr Blood Cancer 2008;51:495-498.
6. Sala A, Pencharz P, Barr RD. Children, cancer, and nutrition - A dynamic triangle in review. Cancer 2004;100:677-687.
7. Norman K, Pichard C, Lochs H, et al. Prognostic impact of disease-related malnutrition. Clin Nutr 2008;27:5-15.
8. Israels T, van de Wetering MD, Hesseling P, et al. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer 2009;53:47-52.
9. National Cancer Institute. Common toxicity criteria V3.0. 2003.
10. Israels T, Damen CW, Cole M, et al. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. Eur J Cancer
11. Hadley GP, Shaik AS. The morbidity and outcome of surgery in children with large pre-treated Wilms' tumour: size matters. Pediatr Surg Int 2006;22:409-412.
12. Madani A, Zafad S, Harif M, et al. Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco. Pediatr Blood Cancer 2006;46:472-475.
13. de Camargo B, Melaragno R, Saba e Silva N, et al. Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: experience of the Brazilian Wilms' Tumor Study Group. Med Pediatr Oncol 1994;22:258-260.
14. Spreafico F, Pritchard JK, Malogolowkin MH, et al. Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther 2009;9:1807-1815.
15. Gururangan S, Cavazos CM, Ashley D, et al. Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 2002;20:2951-2958.